Before her departure, Rashada, a chemist by training, managed a portfolio spanning basic science to American Indian/Alaska Native-focused health research partnerships to scientific infrastructure and research capacity.
Before his retirement in May 2012, Jim had a long-standing interest in systems biology, promoting its approaches to study cell and molecular biology. He also fostered the development of bacterial informatics, including the establishment of an online genomic resource for the E. coli K12 bacterium.
Vernon, a former biochemistry and chemistry professor, managed grant portfolios spanning the areas of bioinorganic chemistry, bioenergetics and mitochondrial physiology, oxidative stress, and enzymology prior to his retirement in October 2020.
Before leaving NIGMS in December 2020, Julie was the project coordinator for the Institutional Development Award Clinical and Translational Research (IDeA-CTR) program, and managed Centers of Biomedical Research Excellence (COBRE).
Before transferring to the NIH Office of the Director in October 2010, Ravi administered grants in the Division of Cell Biology and Biophysics and was the Institute’s AIDS-related research coordinator. He also was involved in several NIH Common Fund programs, including the NIH Director’s Pioneer and New Innovator Awards and the nanomedicine initiative.
As former NIGMS director, Jeremy oversaw the Institute’s programs to fund biomedical research and to train the next generation of scientists. He was a leader in many NIH-wide activities and also found time to study a variety of molecular recognition processes in his NIH lab.
Before transferring to NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development in January 2012, Bray contributed her expertise in program development, strategic planning, and evaluation to the NIGMS Office of Program Analysis and Evaluation.
Jeremy, an emergency medicine physician with a clinical research background, directs the NIH Office of Emergency Care Research, which was transferred from NIGMS to the National Institute of Neurological Disorders and Stroke in January 2018.
Before transferring to the NIH Office of the Director in October 2017, Emily oversaw the Feedback Loop and other efforts to inform and engage different audiences on NIGMS’ goals, activities, and results.
Before her retirement in March 2017, Jean managed research grants in membrane biochemistry and biophysics, transport and lipid metabolism, and she served as the NIGMS contact for Academic Research Enhancement Awards (R15). Her other activities included supporting the development and maintenance of research resources, such as the Lipidomics Gateway and the PSI:Biology Materials Repository .
Before her retirement in December 2019, Alison handled research and training grants in anesthesiology and peri-operative pain as well as predoctoral training grants on molecular medicine.
Before his departure in October 2019, Luis administered the Maximizing Access to Research Careers (MARC), Undergraduate Research Training Initiative for Student Enhancement (U-RISE) and Graduate Research Training Initiative for Student Enhancement (G-RISE), and the Postbaccalaureate Research Education Program (PREP). He also managed the Diversity Program Consortium’s Sponsored Programs Administration Development (SPAD) and Building Infrastructure Leading to Diversity (BUILD) initiatives, as well as research grants in protein folding and degradation.
Before his retirement in May 2019, Jim managed grants on cell division, motility, and organization, and on technology development of light microscopy.
Before transferring to the NIH Office of the Director in January 2017, Régine, who trained in family care and environmental and occupational medicine, managed grants supported through the Institutional Development Award (IDeA) program as well as the dual-degree predoctoral F30 fellowship program.
Jilliene wrote about NIGMS diversity programs and also disseminated information about NIGMS-funded research and programs through a number of outreach activities, events, and meetings.
Prior to her transfer to the National Center for Advancing Translational Sciences in September 2020, Sarah managed a variety of grants involving innate immunity, inflammation, and sepsis. She was the primary contact for information about NIGMS-funded sepsis research.
Before her retirement in December 2014, Irene was our expert on evolutionary biology and managed scientific programs to develop models of disease spread as well as models of scientific workforce dynamics.
Before his retirement in August 2017, Charles managed research grants in the development and application of proteomic and structural biology methods and techniques.
Before transferring to NIH’s National Center for Advancing Translational Sciences in January 2018, Jessica managed the Institutional Research and Academic Career Development Awards (IRACDA) and the Postdoctoral Research Associate (PRAT) Program, an intramural training program at NIH.
Before transferring to NIH’s National Institute of Allergy and Infectious Diseases in November 2015, Shawn, a molecular biologist, managed both research and research training programs. Her research portfolio focused on cell growth and differentiation, and her research training portfolio was aimed at increasing the number of historically underrepresented populations pursuing leadership positions in science.
Before transferring to NIH’s Office of the Director in January 2017, Barbara handled research grants in enzymology and biotechnology, including natural products biosynthesis, as well as institutional predoctoral training grants in biotechnology and NIH Pathway to Independence Awards in pharmacology, physiology, and biological chemistry. Barbara played an active role in the International Cooperative Biodiversity Group program, which is co-funded by NIH.
Before transferring to OD/DPCPSI in February 2020, Raffy, a geneticist by training, has conducted and published research on a number of childhood genetic disorders of brain and skeletal muscle. While at NIGMS, he managed multicomponent grants supported through the Institutional Development Award (IDeA) program.
Before transferring to the NIH’s Office of Data Science Strategy, Susan directed the NIGMS division that supports a range of research and training activities, including in the fields of computational biology, bioinformatics, mathematical and statistical biology, and biomedical technology development.
Before her retirement in October 2020, Judith was the deputy director of NIGMS and the acting director of the Division of Biophysics, Biomedical Technology, and Computational Biosciences. In the past, she also served as the acting director of the Institute and as the director of the former Division of Genetics and Developmental Biology. She led the development of the NIGMS strategic plan issued in 2008 and the development and implementation of the NIGMS strategic plan for training issued in 2011.
Until her retirement in early 2019, Ann was director of extramural activities. In this position, she set and coordinated grant funding policies and procedures, and advised staff on the best grants management practices.
Before leaving NIGMS in July 2017, Alison was deputy director of the Division of Training, Workforce Development, and Diversity. She has 30 years of experience in academia, including conducting research, overseeing graduate education at a medical school, serving on and chairing T32 study sections, and directing NIH-funded diversity programs.
Before her retirement in August 2017, Sue specialized in reproductive biology and embryonic development, including the basic biology of embryonic and adult stem cells. She started her career studying the fruit fly’s genetic control of early embryonic and reproductive development.
Lisa, who was trained in psychology and neuroscience, worked as a program analyst in the NIGMS Division of Data Integration, Modeling, and Analytics before moving to the Small Business Administration in June 2020. She used data analysis techniques and behavioral science knowledge to examine NIGMS’ training, research, and funding efforts.
Before his retirement in May 2012, Warren handled research grants in enzymology, particularly those concerned with the chemical and structural basis of catalysis, and he had a long-standing interest in metabolic engineering. He also managed post-award aspects of the NIH Director’s Pioneer Awards program and served as the NIGMS liaison for legislative affairs.
Before her retirement in September 2014, Story directed the National Institute of Neurological Disorders and Stroke and co-chaired the search committee for a new NIGMS director.
Before his retirement in December 2019, Bob, who is trained in synthetic and bioorganic chemistry, managed research grants in organic chemistry. Prior to joining the Institute, he served as a scientific review officer in the NIH Center for Scientific Review and as a program director at the National Cancer Institute.
Until her retirement in January 2017, Cathy directed the NIGMS division that supports basic research and training in cell biology and biophysics. She played an active role in developing new NIH initiatives in single molecule biophysics and live cell imaging.
Before moving to the National Cancer Institute in November 2020, Stefan managed research grants in the areas of cell growth, differentiation, homeostasis, and cell death. He also oversaw small business grants in genetics and developmental biology and institutional training grants in systems and integrative biology.
Originally trained in biochemistry, Alisa wrote about the full range of NIGMS-supported research before transferring to the National Institute of Arthritis and Musculoskeletal and Skin Diseases in April 2020. She managed the NIGMS image and video gallery, and helped foster science education at NIH.
Before transferring to the Department of Veterans Affairs in May 2018, Stephen managed scientific programs in basic behavioral and social science research and in modeling social behavior at multiple scales.
Before her retirement in December 2019, Pamela handled grant portfolios in glycobiology and molecular immunology, served as a project team leader for the NIH Common Fund Glycoscience Program, and was a steering committee member for the NIH Alliance of Glycobiologists for Cancer Research. She chaired the NIH Intramural Glycobiology Scientific Interest Group Steering Committee and the glycobiology interagency working group.
Before his retirement in April 2018, Richard was director of the NIH Center for Scientific Review, which oversees the receipt and referral of about 80,000 NIH grant applications a year.
Before leaving NIGMS in August 2018, Chris communicated about funded research through blog posts and videos.
Until his retirement in January 2014, Clif oversaw the NIGMS Division of Training, Workforce Development, and Diversity (TWD).
Before transferring to the NIH Office of the Director, Office of Extramural Research, in February 2011, Matt was responsible for grants related to DNA repair and recombination and also coordinated SBIR and STTR small business grants for NIGMS.
Until his retirement in December 2020, Peter handled grants on the biophysics of nucleic acids and nucleoprotein complexes and on the biophysics of membranes and membrane proteins. He also managed other programs in the BBCB division and served as the point of contact for the NIGMS Collaborative Program Award for Multidisciplinary Teams (RM1) and NIGMS National and Regional Resources (R24).
Until May 2012, Karin directed the Division of Biomedical Technology, Bioinformatics, and Computational Biology. She also chaired the trans-NIH Biomedical Informatics Science and Technology Initiative and represented NIH in interagency coordination efforts in Networking and Information Technology Research and Development .
Haluk handled research and training grants in the areas of computational biology, bioinformatics, systems biology, mathematical biology, big data, and biomedical technology research resources. He also directed the Joint DMS/NIGMS Initiative to Support Research at the Interface of the Biological and Mathematical Sciences before leaving NIGMS for a position with the NIH Common Fund.
Before transferring to NIH’s National Center for Complementary and Integrative Health in February 2012, Alberto managed research training programs that increase the participation of underrepresented students in biomedical research. He represented NIGMS on the NIH Blueprint for Neuroscience Research.
Until September 2015, Sally was NIH’s deputy director for extramural research. She oversaw the development and implementation of NIH research funding policies, which she discussed on her blog Rock Talk.
Until his retirement in May 2015, Mike was a division director with his hands in several research and training pots: chemistry, biochemistry, biotechnology, pharmacology, anesthesiology, and the physiological response to trauma and burns. He also had a major interest in fostering both drug discovery and development and cooperation between NIH and industry.
Before transferring to the National Center for Advancing Translational Sciences in March 2020, Mercedes managed the research supplements to promote diversity in health-related research and re-entry into biomedical and behavioral research careers, the National Research Mentoring Network, and the Bridges to the Baccalaureate program.
Before his retirement in May 2011, John handled grants in synthetic organic chemistry, natural products chemistry, and high-throughput chemistry. He was heavily involved in chemical methodologies and library development, including a related NIH Roadmap initiative.
Before transferring to NIH’s National Eye Institute in May 2016, Paul worked on various aspects of grants policy. One of his major interests was in IT systems for grant application and administration, including Grants.gov and the eRA Commons.
Before transferring to NIH’s National Institute of Dental and Craniofacial Research in October 2017, Doug co-lead the Biomedical Technology Research Resources program and served as the program director for the Models of Infectious Disease Agent Study. He also was the project team leader for the NIH Common Fund Technology Centers for Networks and Pathways program.
Before his retirement in December 2019, Scott managed grants that examine the body’s responses to burns, traumatic injuries, and surgery at all levels—from molecular and cellular changes to the body-wide reactions seen in critically ill patients.
Until her retirement in April 2016, Helen oversaw the review of a broad range of research, research training, research education, and center grant applications assigned to NIGMS. She also sat on the NIH committee that develops, implements, and evaluates review policies and procedures for all types of grant applications.
Before her retirement in December 2012, Laurie was our expert on the genetics and genomics of behavior and circadian clocks in a wide variety of model organisms. She also managed grants on transcription mechanisms.
As former chief of the financial management branch, Nancy oversaw the NIGMS budget and led a team responsible for developing the Institute’s fiscal management plans, preparing Congressional budget justifications, and coordinating the support of all NIGMS research and training grants.
Before transferring to the NIH Office of Disease Prevention in April 2014, Jen contributed her expertise in program planning, management, and evaluation to scientific programs in bioinformatics and computational biology.
Sarah, the 2015 summer intern in the NIGMS Office of Program Planning, Analysis, and Evaluation, is a math major at James Madison University who collected data for a variety of projects.
Before her retirement in December 2018, Janna managed both experimental and computational projects studying how proteins fold, survive stress, form complex cellular machines, and are removed from cells—and what happens when these processes go awry.
Before her retirement in April 2017, Peggy organized the scientific review of grant applications for programs that seek to increase the diversity of the biomedical research workforce.
Before transferring to the National Cancer Institute in August 2019, Kris oversaw grants in the areas of mutagenesis and the repair of DNA damage. She was also involved in several NIGMS initiatives to promote rigor and reproducibility in biomedical research.
Before her retirement in January 2015, Marion managed grants involving research on cell cycle control, programmed cell death, and stem cells as well as predoctoral training grants in cellular, molecular, and biochemical sciences and molecular medicine. She also administered NIGMS’ Diversity and Career Re-entry Supplements program.
Before her retirement in December 2018, Hinda led efforts to increase the participation of underrepresented students and faculty in biomedical research.